Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  BIOLASE Inc    BIOL

Delayed Quote. Delayed  - 07/29 09:39:58 pm
1.13 USD   -2.59%
07/25 BIOLASE : reg; to Host 2016 Second Quarter Financial Results Confere..
06/01 BIOLASE : to Present at the LD Micro Invitational
05/09 BIOLASE : reports 1Q loss
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

BIOLASE Inc : BIOLASE Expects to Report Positive Cash Flow From Operations for Q4 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/22/2013 | 02:44pm CEST
BIOLASE Expects to Continue to Generate Positive Cash Flow From Operations for 2013 Overall

IRVINE, CA -- (MARKETWIRE) -- 01/22/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that based on preliminary unaudited financial results, the Company expects to report that it generated positive cash flow from operations for Q4 2012.

"We are pleased with our preliminary unaudited financial results for Q4 2012. It is rewarding to see that our restructuring efforts over the past two years have enabled us to turn the Company around and that we are making significant progress toward achieving our financial goals," said Federico Pignatelli, Chairman and CEO. "The trends we are seeing in the adoption of dental lasers also give us confidence in achieving continued double-digit growth of our core dental franchise. Based on our current plans, we expect the Company will continue to generate positive cash flow from operations for the overall year ending December 31, 2013."

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 290 patented and patent-pending technologies designed to provide biological treatment and clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment and CAD/CAM systems. BIOLASE has sold more than 21,000 lasers.

Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

For further information, please contact:
Lisa Wilson
In-Site Communications, Inc.
212-759-3929


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOLASE INC
07/25 BIOLASE : reg; to Host 2016 Second Quarter Financial Results Conference Call on ..
06/08 BIOLASE, INC : Regulation FD Disclosure, Financial Statements and Exhibits (form..
06/01 BIOLASE : to Present at the LD Micro Invitational
05/12 BIOLASE, INC : Submission of Matters to a Vote of Security Holders (form 8-K)
05/09 BIOLASE, INC : Results of Operations and Financial Condition, Financial Statemen..
05/09 BIOLASE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
05/09 BIOLASE : reports 1Q loss
05/09 BIOLASE : Reports 2016 First Quarter Results
05/09 BIOLASE : Reports 2016 First Quarter Results
05/04 BIOLASE : Names New Vice Presidents of Marketing and Human Resources
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09:05aDJSony Reports Surprise Profit
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28DJTHERMO FISHER SCIENTIFIC : Beats Expectations, Raises Outlook
07/25DJADRs End Lower; Philips Rises
07/25DJPHILIPS : Cost Savings, Strong Sales Boost Philips' Earnings
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
05/11 Midday Gainers / Losers
05/09 BIOLASE's (BIOL) CEO Harold Flynn on Q1 2016 Results - Earnings Call Transcri..
05/09 Biolase misses by $0.03, misses on revenue
03/09 BIOLASE's (BIOL) CEO Harold Flynn on Q4 2015 Results - Earnings Call Transcri..
03/09 Biolase beats by $0.07, beats on revenue
Advertisement
Financials ($)
Sales 2016 51,5 M
EBIT 2016 -12,5 M
Net income 2016 -12,4 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 1,31x
Capi. / Sales 2017 1,22x
Capitalization 67,6 M
More Financials
Chart BIOLASE INC
Duration : Period :
BIOLASE Inc Technical Analysis Chart | BIOL | US0909111082 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 2,00 $
Spread / Average Target 72%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Harold C. Flynn President, Chief Executive Officer & Director
Paul N. Clark Chairman
Richard R. Whipp Vice President-Operations
David C. Dreyer Chief Financial Officer & Senior Vice President
Dmitri Boutoussov Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOLASE INC30.78%68
THERMO FISHER SCIENTIF..11.96%62 498
BOSTON SCIENTIFIC CORP..32.00%33 026
INTUITIVE SURGICAL, IN..26.35%26 564
PHILIPS1.66%25 167
ILLUMINA, INC.-13.30%24 497
More Results